Mesenchymal stromal cells but not cardiac fibroblasts exert beneficial systemic immunomodulatory effects in experimental myocarditis.
Savvatis K, van Linthout S, Miteva K, Pappritz K, Westermann D, Schefold JC, Fusch G, Weithäuser A, Rauch U, Becher PM, Klingel K, Ringe J, Kurtz A, Schultheiss HP, Tschöpe C.
Savvatis K, et al. Among authors: van linthout s.
PLoS One. 2012;7(7):e41047. doi: 10.1371/journal.pone.0041047. Epub 2012 Jul 17.
PLoS One. 2012.
PMID: 22815907
Free PMC article.